GeneDx Holdings's total current liabilities is $75M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
GeneDx Holdings (WGS) currently reports a total current liabilities of $75M as of June 2026. That compares with $71M in the prior-year period — up 4.5% year over year. Use the charts on this page to explore GeneDx Holdings's total current liabilities history and peer comparisons.
GeneDx Holdings's total current liabilities increased from $71M to $75M — a 4.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
GeneDx Holdings reported $75M in total current liabilities as of June 2026. That compares with $71M in the prior-year period — up 4.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $75M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GeneDx Holdings, and consider following WGS for alerts when major investors trade the stock.
GeneDx Holdings is classified in the Healthcare sector. On total current liabilities, it currently shows $75M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WGS with unrelated industries.